Optimized production of Tb-155 by mass separation using Ta-based target materials at the CERN-MEDICIS facility
Rattachement africain : lv, ch. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Terbium isotopes are of considerable interest for medical theranostics; however, their efficient off-line mass separation is constrained by short half-lives and limitations of indirect collection techniques. In this work, an optimized strategy for the production and separation of $$^{155}$$ 155 Tb at the CERN-MEDICIS facility is presented through a comparative study of three tantalum-based target materials: metallic Ta foils, TaC pellets, and a TaC-MWCNT (multi-walled carbon nanotube) composite. Metallic Ta foils exhibit low collection efficiency and are significantly affected by pseudo-isobaric contamination from 139 Ce. In contrast, TaC-based targets, when operated with CF 4 injection, enable direct molecular extraction of 155 Tb as volatile $$\hbox {TbF}_{X}$$ TbF X species, avoiding reliance on indirect 155 Dy collection and effectively suppressing Ce contamination. The modified TaC+C configuration achieved the highest initial collection efficiency (up to 1.74%); however, their performance degraded upon repeated use. By comparison, the TaC-MWCNT composite showed encouraging consistency across the two high-temperature collection runs performed, with process efficiencies of 0.40% and 0.37%. Complementary microstructural characterization indicates that MWCNT incorporation is associated with reduced grain growth and greater retention of open porosity after high-temperature treatment. These results identify CF $$_4$$ 4 -assisted molecular extraction from carbide-based targets as a promising route for high-purity $$^{155}$$ 155 Tb separation. The TaC–MWCNT composite shows encouraging repeatability across the two runs performed, while additional reuse cycles are required to establish long-term reproducibility and thermal stability.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Optimized production of Tb-155 by mass separation using Ta-based target materials at the CERN-MEDICIS facility
- Date Crossref
- 15/09/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.